RHYTHM BIOSCIENCES LTD(RHY.AU),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community

RHY.AU RHYTHM BIOSCIENCES LTD

Closed 05-14 16:12:00 AEST

0.08

+0.00

-3.70%

High0.08	Low0.08	Vol23.00K
Open0.08	D1 Closing0.08	Amplitude1.23%
Mkt Cap19.19M	Tradable Cap13.16M	Total Shares245.98M
T/O1.79K	T/O Rate0.01%	Tradable Shares168.75M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

{"stockData":{"symbol":"RHY.AU","market":"AU","secType":"STK","nameCN":"RHYTHM BIOSCIENCES LTD","latestPrice":0.078,"timestamp":1715667120000,"preClose":0.081,"halted":0,"volume":23000,"delay":0,"nameEN":"RHYTHM BIOSCIENCES LTD","floatShares":168748293,"shares":245982060,"eps":-0.039371,"marketStatus":"Closed","change":-0.003,"latestTime":"05-14 16:12:00 AEST","open":0.077,"high":0.078,"low":0.077,"amount":1786,"amplitude":0.012346,"askPrice":0.078,"askSize":2500,"bidPrice":0.076,"bidSize":12645,"shortable":3,"etf":0,"ttmEps":-0.039371,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":0,"beginTime":1715731200000},"marketStatusCode":5,"adr":0,"exchange":"ASX","adjPreClose":0.081,"openAndCloseTimeList":[[1715644800000,1715666400000]],"volumeRatio":0.169985,"lotSize":1,"tradeCurrency":"AUD"},"requestUrl":"/m/hq/s/RHY.AU/","defaultTab":"news","newsList":[{"id":"2429173416","title":"BRIEF-Rhythm Biosciences Appoints David Atkins As CEO","url":"https://stock-news.laohu8.com/highlight/detail?id=2429173416","media":"Reuters","top":-1,"share":"https://ttm.financial/m/news/2429173416?lang=en_us&edition=fundamental","pubTime":"2024-04-24 09:21","pubTimestamp":1713921709,"startTime":"0","endTime":"0","summary":"April 24 (Reuters) - Rhythm Biosciences Ltd   :   * DAVID ATKINS APPOINTED CHIEF EXECUTIVE OFFICER   * OTTO BUTTULA, EXECUTIVE CHAIRMAN INTENDS TO STEP BACK TO NON-EXECUTIVE POSITIONFurther company coverage:    ((Reuters.Briefs@thomsonreuters.com;))","market":null,"thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2422883627","title":"One Rhythm Biosciences Insider Raised Their Stake In The Previous Year","url":"https://stock-news.laohu8.com/highlight/detail?id=2422883627","media":"Simply Wall St.","top":-1,"share":"https://ttm.financial/m/news/2422883627?lang=en_us&edition=fundamental","pubTime":"2024-03-27 04:33","pubTimestamp":1711485184,"startTime":"0","endTime":"0","summary":"Looking at Rhythm Biosciences Limited's  insider transactions over the last year, we can see that insiders were net buyers. That is, there were more number of shares purchased by insiders than there were sold.While insider transactions are not the most important thing when it comes to long-term investing, we do think it is perfectly logical to keep tabs on what insiders are doing.Rhythm Biosciences Insider Transactions Over The Last Year. Rhythm Biosciences is not the only stock insiders are buying. So take a peek at this free list of growing companies with insider buying.So What Does This Data Suggest About Rhythm Biosciences Insiders?For the purposes of this article, insiders are those individuals who report their transactions to the relevant regulatory body. We currently account for open market transactions an","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/wPCaEqo0Eoh8gNU.SS4ZzA--~B/aD00MzI7dz0xMTk0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/5bcfe52095f73041f79c669b593d7118","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/wPCaEqo0Eoh8gNU.SS4ZzA--~B/aD00MzI7dz0xMTk0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/5bcfe52095f73041f79c669b593d7118"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/one-rhythm-biosciences-insider-raised-203304720.html","is_publish_highlight":false,"gpt_icon":0},{"id":"2421766033","title":"Rhythm Biosciences (ASX:RHY) raises $2.5M in rights issue to advance cancer diagnostics","url":"https://stock-news.laohu8.com/highlight/detail?id=2421766033","media":"Grafa","top":-1,"share":"https://ttm.financial/m/news/2421766033?lang=en_us&edition=fundamental","pubTime":"2024-03-21 09:43","pubTimestamp":1710985384,"startTime":"0","endTime":"0","summary":"Rhythm Biosciences, an Australian firm specialising in predictive cancer diagnostics, closed its rights issue, raising $2.5 million.The effort aligns with the company's commitment to advancing cancer detection through innovative blood tests.The remaining shortfall shares are placed with an open commitment book for interest registration.Shares and options were allotted on March 21, with new share trading beginning on March 22.","market":null,"thumbnail":"https://images.grafa.com/grafa/media-198581-638465821805769032.jpg","type":0,"news_type":0,"thumbnails":["https://images.grafa.com/grafa/media-198581-638465821805769032.jpg"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://grafa.com/news/rhythm-biosciences--asx-rhy--raises--2-5m-in-rights-issue-to-advance-cancer-diagnostics-198581?referralcode=A314DFDBE96C354756A893C6E3E02493","is_publish_highlight":false,"gpt_icon":0},{"id":"2420298022","title":"Rhythm Biosciences (ASX:RHY) launches clinical advisory board to propel ColoSTAT test","url":"https://stock-news.laohu8.com/highlight/detail?id=2420298022","media":"Grafa","top":-1,"share":"https://ttm.financial/m/news/2420298022?lang=en_us&edition=fundamental","pubTime":"2024-03-19 13:00","pubTimestamp":1710824414,"startTime":"0","endTime":"0","summary":"Rhythm Biosciences has established a clinical advisory board to advance its ColoSTAT test kit for early detection of colorectal cancer.The initiative reflects Rhythm's commitment to improving colorectal cancer screening with a precise, safe, and efficient test.The CAB will guide Rhythm on scientific, clinical, and regulatory matters, ensuring international market readiness.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://grafa.com/news/rhythm-biosciences--asx-rhy--launches-clinical-advisory-board-to-propel-colostat-test-197555?referralcode=A314DFDBE96C354756A893C6E3E02493","is_publish_highlight":false,"gpt_icon":0},{"id":"2411501190","title":"BRIEF-Rhythm Biosciences Sats Significant Cost Reduction Program Continues","url":"https://stock-news.laohu8.com/highlight/detail?id=2411501190","media":"Reuters","top":-1,"share":"https://ttm.financial/m/news/2411501190?lang=en_us&edition=fundamental","pubTime":"2024-02-16 09:31","pubTimestamp":1708047103,"startTime":"0","endTime":"0","summary":"Feb 16 (Reuters) - Rhythm Biosciences Ltd   :   * SIGNIFICANT COST REDUCTION PROGRAM CONTINUES, WITH ONGOING CASH-BURN MARKEDLY REDUCEDSource text for Eikon:    Further company coverage:    ((Reuters.Briefs@thomsonreuters.com;))","market":null,"thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2410772780","title":"BRIEF-Rhythm Biosciences Says Rights Issue Offer To Raise Up To A$6.6 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2410772780","media":"Reuters","top":-1,"share":"https://ttm.financial/m/news/2410772780?lang=en_us&edition=fundamental","pubTime":"2024-02-09 09:02","pubTimestamp":1707440569,"startTime":"0","endTime":"0","summary":"Feb 9 (Reuters) - Rhythm Biosciences Ltd   :   * RIGHTS ISSUE OFFER TO RAISE UP TO A$6.6 MILLION   * ISSUE PRICE UNDER OFFER OF A$0.10 PER NEW SHARESource text for Eikon:    Further company coverage:    ((Reuters.Briefs@thomsonreuters.com;))","market":null,"thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2409232511","title":"BRIEF-Rhythm Biosciences Seeks Trading Halt","url":"https://stock-news.laohu8.com/highlight/detail?id=2409232511","media":"Reuters","top":-1,"share":"https://ttm.financial/m/news/2409232511?lang=en_us&edition=fundamental","pubTime":"2024-02-07 06:00","pubTimestamp":1707256825,"startTime":"0","endTime":"0","summary":"Feb 7 (Reuters) - Rhythm Biosciences Ltd   :   * SEEKS TRADING HALT PENDING ANNOUNCEMENT OF PROPOSED CAPITAL RAISINGSource text for Eikon:    Further company coverage:    ((Reuters.Briefs@thomsonreuters.com;))","market":null,"thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2408600566","title":"Rhythm Biosciences Insider Purchases Yet To Pay Off Regardless Of Recent Strength","url":"https://stock-news.laohu8.com/highlight/detail?id=2408600566","media":"Simply Wall St.","top":-1,"share":"https://ttm.financial/m/news/2408600566?lang=en_us&edition=fundamental","pubTime":"2024-02-02 05:19","pubTimestamp":1706822361,"startTime":"0","endTime":"0","summary":"Insiders who bought AU$248.2k worth of Rhythm Biosciences Limited ( ASX:RHY ) stock in the last year have seen some of...","market":"hk","thumbnail":"https://images.simplywall.st/asset/industry/6032000-choice1-main-header/1585186661957","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6032000-choice1-main-header/1585186661957"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/healthcare/asx-rhy/rhythm-biosciences-shares/news/rhythm-biosciences-insider-purchases-yet-to-pay-off-regardle","is_publish_highlight":false,"gpt_icon":0},{"id":"2395097444","title":"Companies Like Rhythm Biosciences (ASX:RHY) Could Be Quite Risky","url":"https://stock-news.laohu8.com/highlight/detail?id=2395097444","media":"Simply Wall St.","top":-1,"share":"https://ttm.financial/m/news/2395097444?lang=en_us&edition=fundamental","pubTime":"2023-12-31 06:32","pubTimestamp":1703975520,"startTime":"0","endTime":"0","summary":"Even when a business is losing money, it's possible for shareholders to make money if they buy a good business at the right price. For example, although software-as-a-service business Salesforce.com lost money for years while it grew recurring revenue, if you held shares since 2005, you'd have done very well indeed. But while the successes are well known, investors should not ignore the very many unprofitable companies that simply burn through all their cash and collapse.So should Rhythm Biosciences  shareholders be worried about its cash burn?In this report, we will consider the company's annual negative free cash flow, henceforth referring to it as the 'cash burn'. First, we'll determine its cash runway by comparing its cash burn with its cash reserves.Check out our latest analysis for Rhythm Biosciences. Rhythm Biosciences has a market capitalisation of AU$30m and burnt through AU$7.1m last year, which is 24% of the company's market value. That's not insignificant, and if the compan","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/wPCaEqo0Eoh8gNU.SS4ZzA--~B/aD00MzI7dz0xMTk0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/5bcfe52095f73041f79c669b593d7118","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/wPCaEqo0Eoh8gNU.SS4ZzA--~B/aD00MzI7dz0xMTk0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/5bcfe52095f73041f79c669b593d7118"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/companies-rhythm-biosciences-asx-rhy-223200585.html","is_publish_highlight":false,"gpt_icon":0},{"id":"2392936781","title":"BUZZ-Australia's Rhythm Biosciences hits over 3-year low on nil product revenue forecast","url":"https://stock-news.laohu8.com/highlight/detail?id=2392936781","media":"Reuters","top":-1,"share":"https://ttm.financial/m/news/2392936781?lang=en_us&edition=fundamental","pubTime":"2023-12-18 10:08","pubTimestamp":1702865285,"startTime":"0","endTime":"0","summary":"** Shares of Rhythm Biosciences    drop as much as 35.1% to A$0.120, hitting their lowest level since Sept 9, 2020   ** Stock faces worst day since Oct 12, if losses hold   ** Biotechnology co says it completed strategic review across entire business   ** Co says ColoSTAT kits produced will be used for research only rather than commercial sales   ** RHY does not anticipate any material revenue for its existing kits   ** More than 1.7 mln shares change hands, 9.5 times the 30-day average volume of 181,138 shares   ** Stock down 81.3% YTD, as of last close ","market":null,"thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2389206792","title":"Is Rhythm Biosciences (ASX:RHY) In A Good Position To Deliver On Growth Plans?","url":"https://stock-news.laohu8.com/highlight/detail?id=2389206792","media":"Simply Wall St.","top":-1,"share":"https://ttm.financial/m/news/2389206792?lang=en_us&edition=fundamental","pubTime":"2023-12-07 05:34","pubTimestamp":1701898458,"startTime":"0","endTime":"0","summary":"Even when a business is losing money, it's possible for shareholders to make money if they buy a good business at the...","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/6032000-choice1-main-header/1585186661957","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6032000-choice1-main-header/1585186661957"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/healthcare/asx-rhy/rhythm-biosciences-shares/news/is-rhythm-biosciences-asxrhy-in-a-good-position-to-deliver-o","is_publish_highlight":false,"gpt_icon":0},{"id":"2385605657","title":"Rhythm Biosciences flags positive data for lung cancer diagnostic test","url":"https://stock-news.laohu8.com/highlight/detail?id=2385605657","media":"The Market Herald","top":-1,"share":"https://ttm.financial/m/news/2385605657?lang=en_us&edition=fundamental","pubTime":"2023-11-24 10:34","pubTimestamp":1700793240,"startTime":"0","endTime":"0","summary":"Together with the Baker Institute, Rhythm identifies best five-biomarker combination that can target the various stages of lung cancer. The company used a cohort of 70 healthy and cancerous patients. The results could lead to these biomarkers being translated into a commercial treatment. Rhythm Biosciences  has received positive preliminary data from the Baker Institute in regard to its lung cancer diagnostic test.Rhythm reports successfully identifying a five-biomarker combination that can target the various stages of lung cancer.A preliminary assessment of up to 17 biomarkers was performed on 71 healthy volunteers and 70 lung cancer patients.Shares, however, remained flat in the second hour of trade.Originally for research only, these biomarkers have proven they can distinguish between healthy and cancerous controls.Rhythm has stated the results require further analysis through a larger cohort to justify continuing the project.This it expects to support the case for further investmen","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://themarketherald.com.au/rhythm-biosciences-flags-positive-data-for-lung-cancer-diagnostic-test-2023-11-24/","is_publish_highlight":false,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.rhythmbio.com","stockEarnings":[{"period":"1week","weight":-0.0122},{"period":"1month","weight":-0.1099},{"period":"3month","weight":-0.325},{"period":"6month","weight":-0.595},{"period":"1year","weight":-0.775},{"period":"ytd","weight":-0.4}],"compareEarnings":[{"period":"1week","weight":0.0243},{"period":"1month","weight":0.0515},{"period":"3month","weight":0.1027},{"period":"6month","weight":0.1358},{"period":"1year","weight":0.1468},{"period":"ytd","weight":0.1193}],"compareStock":{"symbol":"F100.AU","name":"BETASHARES FTSE 100 ETF"},"description":"Rhythm Biosciences Limited, a medical diagnostics technology company, engages in developing and commercializing medical diagnostics technology in Australia and internationally. It is developing ColoSTAT, a test for the early detection of colorectal cancer. The company was incorporated in 2017 and is headquartered in Melbourne, Australia.","yearOnYearQuotes":[{"month":1,"riseRate":0.142857,"avgChangeRate":-0.092762},{"month":2,"riseRate":0.285714,"avgChangeRate":-0.097735},{"month":3,"riseRate":0.428571,"avgChangeRate":0.099034},{"month":4,"riseRate":0.285714,"avgChangeRate":-0.053147},{"month":5,"riseRate":0.333333,"avgChangeRate":-0.032998},{"month":6,"riseRate":0.833333,"avgChangeRate":0.092623},{"month":7,"riseRate":0.333333,"avgChangeRate":-0.036147},{"month":8,"riseRate":0.5,"avgChangeRate":0.24613},{"month":9,"riseRate":0.333333,"avgChangeRate":-0.065809},{"month":10,"riseRate":0.333333,"avgChangeRate":0.270014},{"month":11,"riseRate":0.166667,"avgChangeRate":-0.012372},{"month":12,"riseRate":0.428571,"avgChangeRate":-0.013075}],"exchange":"ASX","name":"RHYTHM BIOSCIENCES LTD","nameEN":"RHYTHM BIOSCIENCES LTD"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.22.4","shortVersion":"4.22.4","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"RHYTHM BIOSCIENCES LTD(RHY.AU),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest RHYTHM BIOSCIENCES LTD(RHY.AU) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"RHYTHM BIOSCIENCES LTD,RHY.AU,RHYTHM BIOSCIENCES LTD股票,RHYTHM BIOSCIENCES LTD股票老虎,RHYTHM BIOSCIENCES LTD股票老虎国际,RHYTHM BIOSCIENCES LTD行情,RHYTHM BIOSCIENCES LTD股票行情,RHYTHM BIOSCIENCES LTD股价,RHYTHM BIOSCIENCES LTD股市,RHYTHM BIOSCIENCES LTD股票价格,RHYTHM BIOSCIENCES LTD股票交易,RHYTHM BIOSCIENCES LTD股票购买,RHYTHM BIOSCIENCES LTD股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"RHYTHM BIOSCIENCES LTD(RHY.AU),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest RHYTHM BIOSCIENCES LTD(RHY.AU) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}

Introduction